EuroAPI Logo

EuroAPI

Develops and manufactures APIs and provides CDMO services for complex molecules.

EAPI | PA

Overview

Corporate Details

ISIN(s):
FR0014008VX5 (+2 more)
LEI:
9695002FT7GGI3CKKJ14
Country:
France
Address:
15 RUE TRAVERSIERE, 75012 PARIS

Description

EuroAPI is a developer and manufacturer of Active Pharmaceutical Ingredients (APIs), focusing on small and complex molecules. The company's business is centered on two main activities: offering API solutions from its large portfolio and providing Contract Development and Manufacturing Organization (CDMO) services. The product portfolio contains over 200 ingredients, with expertise in categories such as opiates and controlled substances, prostaglandins, corticoids, hormones, anti-infectives, and Vitamin B12. As a CDMO, EuroAPI provides services for complex chemistry, including small molecule synthesis, microbial fermentation, particle engineering (micronization and spray drying), and the development of lipids and tides like oligonucleotides, serving a global customer base.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-01 17:39
Mise à disposition du Document d’Enregistrement Universel 2024, contenant le Ra…
French 441.8 KB
2025-04-01 17:39
Availability of the 2024 Universal Registration Document, including the Annual …
English 438.0 KB
2025-04-01 12:11
Universal Registration Document 2024
English 89.9 MB
2025-03-10 15:29
Franchissement de seuil
French 218.5 KB
2025-03-10 12:49
Franchissement de seuil
French 104.7 KB
2025-03-10 10:59
Franchissement de seuils
French 218.6 KB
2025-03-10 10:40
Franchissement de seuils
French 220.3 KB
2025-03-03 18:35
Résultats 2024 - Progrès dans la mise en œuvre du plan FOCUS-27 soutenue par un…
French 932.4 KB
2025-03-03 18:35
Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan dr…
English 912.9 KB
2025-02-21 14:40
Franchissement de seuils
French 218.1 KB
2025-02-14 12:15
Franchissement de seuils
French 220.8 KB
2025-02-11 13:55
Franchissement de seuils
French 220.0 KB
2025-02-06 10:26
Franchissement de seuils
French 221.2 KB
2025-01-31 14:23
Franchissements de seuils
French 230.9 KB
2025-01-06 17:40
EUROAPI accueille le ministre de la Santé et de l’Accès aux soins Yannick Neude…
French 721.5 KB

Automate Your Workflow. Get a real-time feed of all EuroAPI filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EuroAPI

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EuroAPI via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bone Biologics Corp Logo
Develops a protein-based bone graft substitute for spinal fusion procedures.
United States of America
BBLG
Bonyf N.V. Logo
Develops medical devices for oral, dental, orthodontic, and dermatological care.
Belgium
MLBON
Boryung Corporation Logo
A healthcare company developing pharmaceuticals and investing in health sector innovation.
South Korea
003850
Bosnalijek d.d. Sarajevo Logo
Develops, manufactures, and exports a wide range of pharmaceutical products.
Bosnia and Herzegovina
BSNL
Boule Diagnostics Logo
Provider of hematology systems for decentralized human and veterinary markets.
Sweden
BOUL
Boundless Bio, Inc. Logo
Clinical-stage oncology company targeting ecDNA in oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma developing inhibitors for genetically driven cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Develops selective serotonin agonists for neurological and psychiatric disorders.
United States of America
DRUG
A clinical-stage biopharma company developing cancer immunotherapies and cell therapies.
Japan
4594

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.